The items were successfully added to the cart.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. Find out more






Choose your prefered product category above

SEP 2ND, 2019

Mercodia Webinar: Novel Polypharmacological Treatment Options for Obesity and Diabetes

Welcome to this Mercodia webinar by Dr Timo Müller that will include an introduction to the physiology and pathophysiology of GIP and GLP-1 in metabolic diseases and treatment strategies based on (poly-)agonists of incretins and related hormones.

Thu, Sep 12, 2019 4:00 PM - 5:00 PM CEST Dr. Timo Müller Director (acting), Institute for Diabetes and Obesity, Helmholtz Center, Munich, Germany.

MAY 3RD, 2019

Fascinating findings on islet cell plasticity

In a recent Nature publication, researchers show that human pancreatic non-beta-cells (alpha and gamma cells) can be reprogrammed to produce and secrete insulin in response to glucose.


MAY 16TH, 2019

Recommendations for classification of commercial LBA kits for biomarkers in drug development

A White Paper has recently been published that reports the Global Contract Research Organization Council members’ opinion on the challenges facing the industry and their recommendations on the classification of commercial kits that can be a win-win for commercial kit vendors and end users.


Latest Tweet
Mercodia @Mercodia Sep 20th, 2019
Did you miss our webinar with Dr Timo Müller from @helmholtz_diabc last week? Don't worry, you can watch it on dem…

NOV 16TH, 2017

How to choose your glucagon assay

How does one choose which glucagon assay to use? What is important to think about regarding sensitivity, matrix interference and cross-reactivity?


Find answers to these questions: 

  • Why measure total GLP-1?
  • Why is amidated GLP-1 so important?
  • What is the expected level of GLP-1 in different patient samples?
  • How is GLP-1 targeted in treatment strategies?

Altered Levels of Glucagon and Glicentin in Adolescents With Obesity and Type 2 Diabetes

The prevalence of childhood obesity has increased worldwide in the past decades, which has been accompanied by a rise in obesity-related comorbidities such as type 2 diabetes mellitus (T2DM). 

Mercodia Bioanalytical Service

Mercodia's Bioanalytical Service provides you with the experience, quality and reliability that are fundamental to a productive partnership. Our experienced team of managers, scientists, technicians and regulatory resources will support you in everything from study design to sample handling. We follow the most recent international guidelines and industry standard white papers for bioanalytical method development and validation.

Our combined expertise will ensure that your studies of PK, PD and biomarkers are performed with the highest possible measurement quality, enabling you to make informed decisions based on accurate bioanalytical data. We are highly flexible in the transfer of data in different formats, to meet individual sponsor needs. 


WHITE PAPER on GLUCAGON MEASUREMENT Addressing Long-Standing Analytical Challenges



  • What technical aspects of commercial glucagon assays have prevented them from meeting scientists’ needs? 
  • Are there analytical solutions available to meet those needs?



Exploring Frontiers in Translational Research
Learn about scientific advances that lead to a better understanding of diseases and therapies. Interviews with scientists and clinicians will provide you with cutting-edge information, coming directly from the source.  Explore topics ranging from drug discovery and new FDA regulations to novel approaches to metabolic diseases (e.g., diabetes and heart disease).


At Mercodia, we pride ourselves on providing our customers with quick, accurate support. Below you will find answers to some common questions. If you do not find what you are looking for, please feel free to contact us: contacts


Our professional and experienced Customer Service and Technical Support teams are dedicated to ensuring complete customer satisfaction.